Robert's carrier screen

Genetic Testing

what it means — and how we match every future donor
🧬 The one thing to check on every donor

Robert's carrier screen came back with one meaningful finding: he is a carrier of Oculocutaneous Albinism Type 4 (OCA4), in the gene SLC45A2. He is perfectly healthy — carriers almost never have symptoms.

OCA4 is recessive, which means a baby can only be affected if both genetic parents carry a change in the same gene. So for every egg donor we consider, there is really just one box to check:

Is she also a carrier of SLC45A2 (OCA4)?

Because every other gene on Rob's 556-gene panel was negative, SLC45A2 is the single gene we watch when a donor's screen comes in.

Plain English

What it means

What is OCA4? Oculocutaneous albinism type 4 is a condition that reduces melanin — the pigment that colors skin, hair and eyes. Affected people have lighter pigmentation and some vision differences (reduced sharpness, sensitivity to light, involuntary eye movement). Sun protection matters because of higher skin-cancer risk. Intelligence is not affected, and vision typically stabilizes after childhood.

What does “carrier” mean for Rob? He has one changed copy of SLC45A2 and one normal copy. One changed copy causes no health problems — he simply carries it. It only matters for family planning, when it's combined with the egg side.

The recessive math (why the donor is the whole question): a child needs a changed copy from both sides to be affected. Rob will pass his changed copy to about half of embryos no matter what. So the outcome rides entirely on the donor:

Donor is not an OCA4 carrier → 0% chance a child is affected (some kids may be silent carriers).  •  Donor is also an OCA4 carrier → 25% of children affected, 50% carriers, 25% neither.

What to look out for as donor screens arrive: we only need to see the donor's carrier-screen line for SLC45A2 / OCA4. Most donors are pre-screened by the bank, so this is usually a quick confirm — but it must be confirmed for each one, ideally by IVFMD's genetic counselor.

The report on file

Robert's Results

Invitae Comprehensive Carrier Screen — 556 genes · blood draw Mar 2023 · report updated Nov 6, 2023.

FindingGene / variantDetailResult
Oculocutaneous albinism type 4 (OCA4)SLC45A2 c.1504G>A (p.Gly502Arg), heterozygous — Likely PathogenicAutosomal recessive. Carrier frequency ~1 in 158. Partner (donor) testing recommended.Carrier
Cystic FibrosisCFTRNo variant detected.Negative
Spinal Muscular AtrophySMN12 copies; negative.Negative
Fragile XFMR1Normal (29 CGG repeats).Normal
All other 552 genes—No other clinically significant changes identified.Negative

📄 View Robert's full Invitae report (PDF)

Match future donors here

Donor Match Board

As each donor's carrier screen comes in, add her below. The board flags the only thing that matters for us: whether she also carries SLC45A2 (OCA4). Your entries are saved on this device.

DonorBank / agencyOCA4 matchNotes
How to read it: ✓ Clear for OCA4 = safe on this condition. ⚠ Both carriers = pick another donor or use PGT-M. ⌛ Pending = still waiting on her screen. Want me to add a donor for you? Send Rob her carrier-screen page and I'll log her here.
This page organizes Robert's own Invitae carrier-screen report for convenient reference and donor matching. It is not medical advice and carrier screening is not diagnostic. Please have IVFMD's genetic counselor confirm every donor cross-match and interpret any result before decisions are made.

🕊   Made for Michelle & Robert — one more step toward your family.
Version 2.3 · updated Jul 22, 2026 · 10:11 PM ET